Hydromer, traded on the OTCMKTS under the symbol HYDI, is a specialty materials company focused on the development and commercialization of advanced polymer coatings, adhesives and hydrogels. Headquartered in Pomona, California, Hydromer supplies proprietary hydrophilic and hydrophobic coatings that enhance the surface properties of medical devices, diagnostic test components, and industrial membranes. Its technology platform encompasses water-based polymer chemistries designed to improve lubricity, biocompatibility, barrier protection and controlled release characteristics.
The company’s core product lines include coatings for catheter, guidewire and endovascular device applications, as well as proprietary hydrogel formulations for drug-delivery matrices and tissue engineering scaffolds. In addition to medical device markets, Hydromer serves the life sciences sector with custom reagents and polymer supports for diagnostic assays, and the water treatment industry with anti-fouling and anti-scaling membrane coatings. Many of its products are sold under exclusive agreements or through licensing partnerships with original equipment manufacturers (OEMs).
Hydromer operates research and manufacturing facilities in Southern California and collaborates with academic institutions and industry partners to expand its polymer science capabilities. Its customer base extends across North America, Europe and Asia, with strategic alliances in key markets for catheter-based therapies and point-of-care diagnostics. The company’s management team comprises industry veterans in polymer chemistry, medical device development and commercial operations, guiding Hydromer’s efforts to translate new coatings technologies into scalable, regulatory-compliant solutions.
AI Generated. May Contain Errors.
Free HYDI Stock Alerts